Global Travel and Tourism Deal Activity Slows in First Half of 2024

The global travel and tourism sector experienced a decline in deal activity during the first half of 2024, with a notable drop in mergers and acquisitions, venture financing, and private equity transactions compared to the same period in 2023. While some regions like Europe saw an increase in deal volume, North America, Asia-Pacific, and South and Central America experienced significant declines. This trend reflects the evolving nature of the global travel and tourism sector.

Stax LLC Promotes Tyler Veit to Managing Director

Stax LLC, a global strategy consulting firm, has promoted Tyler Veit to Managing Director. Veit, who has been with the firm for over seven years, leads Stax’s Business Services vertical and brings extensive experience in tech-enabled services, professional advisory services, and commercial and facility services. His promotion reflects Stax’s commitment to recognizing and supporting talented individuals who contribute to the firm’s success and client satisfaction.

Madison International Realty Appoints Akaash Shah as Vice President of Investments

Madison International Realty, a leading real estate private equity firm, has announced the appointment of Akaash Shah as Vice President of Investments. Based in London, Shah will focus on advancing the firm’s Real Estate Growth Platform Investing activities. Shah brings over a decade of real estate experience, most recently serving as a Principal at Accord Group, where he specialized in sourcing, underwriting, and executing strategic growth capital investments in early-to-mid stage real estate platforms across the UK and Europe.

Ancillary Businesses Around Tech Giants Offer Lucrative Investment Opportunities

Kyle Wool, CEO of Dominari Securities, emphasizes the potential for lucrative investments in ancillary businesses supporting tech giants like Nvidia and Super Micro. Wool highlights the increasing demand for sustainable and efficient power sources for massive data centers, suggesting that nuclear energy is a promising investment opportunity. Companies like Constellation Energy and Talen Energy have seen significant stock growth due to the growing recognition of nuclear’s potential. Wool also discusses private investment opportunities in small nuclear reactors that can power data centers directly. Acclaimed investors Sam Altman and Bill Gates have invested heavily in this sector, recognizing its long-term potential. Wool believes that these investments have the potential for 10 to 20 times returns.

1847 Holdings Expands Reach into Millwork, Cabinetry, and Door Markets

1847 Holdings LLC. (EFSH), a specialized holding company, is expanding its presence in the millwork, cabinetry, and door manufacturing markets by acquiring a leading player in the space. The acquisition target is an ideal fit for 1847, which typically targets businesses with EBITDA of $5 million or more that are overlooked by the marketplace. The acquisition is expected to close in the third quarter of this year and is being financed with debt. 1847 already owns several companies in the home improvement space, including Kyle’s Custom Wood Shop, High Mountain Door & Trim, and Innovative Cabinets & Design, and sees this acquisition as a way to further expand its reach into the commercial side of the business.

CVC Gears Up for Amsterdam Stock Exchange IPO, Targetting €13-€15 Billion Valuation

CVC Capital Partners, a prominent investment firm with stakes in entities such as Six Nations rugby and Lipton Teas, is preparing to list on the Amsterdam Stock Exchange with an estimated valuation ranging from €13 billion to €15 billion. This move will make 114 million shares, priced between €13 and €15 each, accessible to public investors, breaking away from the previous exclusive access for private buyers. The decision to launch this IPO comes after years of planning and a number of postponements due to global events.

KKR Acquires Immedica Pharma, a European Leader in Rare Disease Treatments

KKR, a global investment firm, has acquired Immedica Pharma, a Stockholm-based pharmaceutical company specializing in rare diseases and specialty care products. The acquisition will involve the reinvestment of Immedica’s existing owner, Impilo, which will become an equal owner alongside KKR. The partnership aims to support Immedica’s continued growth, including the launch of its recently approved ultra-orphan drug Loargys, additional pipeline assets, and continued in-licensing and mergers and acquisitions.

Scroll to Top